ANVS
Price
$2.29
Change
+$0.01 (+0.44%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
44.62M
60 days until earnings call
ATXS
Price
$7.53
Change
+$0.53 (+7.57%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
424.39M
68 days until earnings call
Interact to see
Advertisement

ANVS vs ATXS

Header iconANVS vs ATXS Comparison
Open Charts ANVS vs ATXSBanner chart's image
Annovis Bio
Price$2.29
Change+$0.01 (+0.44%)
Volume$542
Capitalization44.62M
Astria Therapeutics
Price$7.53
Change+$0.53 (+7.57%)
Volume$3.67K
Capitalization424.39M
ANVS vs ATXS Comparison Chart in %
Loading...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANVS vs. ATXS commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVS is a Hold and ATXS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ANVS: $2.29 vs. ATXS: $7.52)
Brand notoriety: ANVS and ATXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANVS: 62% vs. ATXS: 202%
Market capitalization -- ANVS: $44.62M vs. ATXS: $424.39M
ANVS [@Biotechnology] is valued at $44.62M. ATXS’s [@Biotechnology] market capitalization is $424.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANVS’s FA Score shows that 1 FA rating(s) are green whileATXS’s FA Score has 0 green FA rating(s).

  • ANVS’s FA Score: 1 green, 4 red.
  • ATXS’s FA Score: 0 green, 5 red.
According to our system of comparison, ANVS is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANVS’s TA Score shows that 4 TA indicator(s) are bullish while ATXS’s TA Score has 6 bullish TA indicator(s).

  • ANVS’s TA Score: 4 bullish, 5 bearish.
  • ATXS’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, ATXS is a better buy in the short-term than ANVS.

Price Growth

ANVS (@Biotechnology) experienced а -0.87% price change this week, while ATXS (@Biotechnology) price change was +21.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

ANVS is expected to report earnings on Nov 05, 2025.

ATXS is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($424M) has a higher market cap than ANVS($44.6M). ATXS YTD gains are higher at: -15.884 vs. ANVS (-54.473). ANVS has higher annual earnings (EBITDA): -23.68M vs. ATXS (-131.42M). ATXS has more cash in the bank: 259M vs. ANVS (17.1M). ANVS (0) and ATXS (0) have equivalent revenues.
ANVSATXSANVS / ATXS
Capitalization44.6M424M11%
EBITDA-23.68M-131.42M18%
Gain YTD-54.473-15.884343%
P/E RatioN/AN/A-
Revenue00-
Total Cash17.1M259M7%
Total DebtN/A4.77M-
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANVSATXS
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 22 days ago
83%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSEIX22.53N/A
N/A
Nicholas Equity Income I
ASVNX9.46N/A
N/A
American Century Small Cap Value C
RAPRX11.05N/A
N/A
Cohen & Steers Real Assets R
CATWF0.07N/A
N/A
China Tontine Wines Group Ltd.
LDDD4.99N/A
N/A
LONGDUODUO CO LTD.